The Pennant Group (PNTG) Competitors $23.35 +0.25 (+1.08%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$23.35 0.00 (0.00%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PNTG vs. SHC, SGRY, CON, PRVA, WGS, VCYT, ARDT, ADUS, PGNY, and PACSShould you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), Ardent Health (ARDT), Addus HomeCare (ADUS), Progyny (PGNY), and PACS Group (PACS). These companies are all part of the "healthcare" industry. The Pennant Group vs. Its Competitors Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Ardent Health Addus HomeCare Progyny PACS Group The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment. Is PNTG or SHC more profitable? The Pennant Group has a net margin of 3.40% compared to Sotera Health's net margin of 2.24%. Sotera Health's return on equity of 41.08% beat The Pennant Group's return on equity.Company Net Margins Return on Equity Return on Assets The Pennant Group3.40% 10.73% 4.00% Sotera Health 2.24%41.08%5.68% Does the media prefer PNTG or SHC? In the previous week, Sotera Health had 2 more articles in the media than The Pennant Group. MarketBeat recorded 7 mentions for Sotera Health and 5 mentions for The Pennant Group. Sotera Health's average media sentiment score of 0.76 beat The Pennant Group's score of 0.68 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Sotera Health 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate PNTG or SHC? The Pennant Group presently has a consensus price target of $33.80, indicating a potential upside of 44.75%. Sotera Health has a consensus price target of $16.00, indicating a potential upside of 30.08%. Given The Pennant Group's higher probable upside, research analysts plainly believe The Pennant Group is more favorable than Sotera Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has more risk and volatility, PNTG or SHC? The Pennant Group has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Do insiders and institutionals believe in PNTG or SHC? 85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 5.4% of The Pennant Group shares are held by insiders. Comparatively, 47.5% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better earnings and valuation, PNTG or SHC? Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThe Pennant Group$695.24M1.16$22.56M$0.7630.72Sotera Health$1.11B3.15$44.34M$0.08153.75 SummarySotera Health beats The Pennant Group on 13 of the 16 factors compared between the two stocks. Get The Pennant Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PNTG vs. The Competition Export to ExcelMetricThe Pennant GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$796.23M$3.78B$5.69B$9.50BDividend YieldN/A1.34%4.58%4.01%P/E Ratio30.7232.7428.1020.05Price / Sales1.16123.93432.4490.07Price / Cash25.0621.9036.2258.56Price / Book2.574.408.665.87Net Income$22.56M$189.47M$3.25B$258.55M7 Day Performance-0.34%2.10%4.23%3.74%1 Month Performance-19.73%-4.24%10.52%11.75%1 Year Performance-20.33%-2.92%34.41%18.03% The Pennant Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PNTGThe Pennant Group3.6036 of 5 stars$23.35+1.1%$33.80+44.8%-20.1%$796.23M$695.24M30.727,000SHCSotera Health3.073 of 5 stars$11.61-1.6%$16.00+37.8%-9.6%$3.30B$1.10B145.143,000News CoveragePositive NewsSGRYSurgery Partners2.9703 of 5 stars$22.47+2.0%$33.56+49.3%-30.9%$2.88B$3.11B-14.6915,000CONConcentra Group Holdings Parent3.1538 of 5 stars$20.23+1.6%$28.50+40.9%N/A$2.59B$1.90B15.0911,250News CoveragePositive NewsPRVAPrivia Health Group4.1575 of 5 stars$20.89+2.1%$28.38+35.9%-1.5%$2.55B$1.80B174.101,140News CoveragePositive NewsWGSGeneDx3.9719 of 5 stars$82.39-0.2%$92.33+12.1%+144.0%$2.35B$330.14M-58.431,200Upcoming EarningsVCYTVeracyte3.6864 of 5 stars$26.65-1.6%$40.90+53.5%+6.3%$2.09B$445.76M65.00790News CoveragePositive NewsAnalyst UpgradeGap UpARDTArdent Health3.5501 of 5 stars$14.51+2.4%$20.67+42.4%-34.7%$2.08B$5.97B8.9024,900ADUSAddus HomeCare4.9631 of 5 stars$111.75+0.7%$142.57+27.6%-9.7%$2.06B$1.15B25.2349,703Positive NewsPGNYProgyny1.0866 of 5 stars$23.47+1.1%$24.09+2.6%-19.2%$2.01B$1.17B41.18310News CoveragePositive NewsAnalyst UpgradePACSPACS Group2.4646 of 5 stars$12.93+1.9%$34.29+165.3%-65.8%$1.97B$3.11B0.0032,433 Related Companies and Tools Related Companies SHC Competitors SGRY Competitors CON Competitors PRVA Competitors WGS Competitors VCYT Competitors ARDT Competitors ADUS Competitors PGNY Competitors PACS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PNTG) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Pennant Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share The Pennant Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PNTG Stock Alerts